The symposium brings together researchers, policymakers, practitioners, and industry leaders to share the latest advances in behavioral science and health, foster collaboration, and explore new ideas to improve health and healthcare. Abstract submissions are currently being accepted for symposium presentations.

The IMPACT Collaboratory requests applications for The James L. Rudolph Career Development Award Program and Pilot Grants Program of non-pharmacological interventions for people living with dementia (PLWD) and their care partners.

Dr. Portacolone will discuss issues associated with screening, consent, recruitment, and eligibility for older adults living alone with cognitive impairment. Building on her experience, including leading a large qualitative study involving multiple interviews (n=486) with over 100 racially and ethnically diverse older adults living alone in 3 states, Dr. Portacolone will also share the protocols from the US-based Living Alone with Cognitive Impairment study.

As the Alzheimer's disease landscape rapidly evolves with new biomarker tools and FDA-approved disease-modifying therapies reshaping how we diagnose and treat, earlier identification and timely intervention have never been more critical to patient outcomes. This session will review early detection approaches using clinical assessments with the latest biomarker tools, discuss appropriate patient selection and use of disease-modifying therapies.